zoster recombinant adjuvanted vaccine (Harvard Medical School/Brigham and Women's Hospital)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namezoster recombinant adjuvanted vaccine (Harvard Medical School/Brigham and Women's Hospital)
Drug Alias Nameherpes zoster vaccine (Harvard Medical School/Brigham and Women's Hospital)
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsVaricella Zoster Virus Infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesHarvard Medical School
China Registration ClassN/A

Develop Information

Active CompaniesThe Brigham and Women's HospitalHarvard Medical School
Inactive CompaniesN/A
Active IndicationsVaricella Zoster Virus Infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A